Joint Clinical Trials Office
Characterization of the Microbiome to Predict Complications in Chronic Kidney Disease and End Stage Kidney Disease Patients
Study Status:
Open to Enrollment
Primary Investigator:
John Richard Lee, M.D.
Date: April 21, 2017
A multicenter safety study of unlicensed, investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patients
Study Status:
Open to Enrollment
Primary Investigator:
Koen van Besien, M.D.
Date: September 22, 2015
A Phase 1 Study With an Expansion Cohort/Randomized Phase 2 Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Lisa Roth, MD
Date: February 21, 2019
ROMA Trial
Study Status:
Open to Enrollment
Primary Investigator:
Mario Gaudino M.D.
Date: February 14, 2018
Pilot study to collect blood from research subjects allergic and non-allergic to peanut to study immune modulation with anti-IgE therapy in mice
Study Status:
Open to Enrollment
Primary Investigator:
Odelya Pagovich, M.D.
Date: September 22, 2015
Advanced Endoscopic Therapies (AETs): A Retrospective and Prospective Multicenter Registry
Study Status:
Open to Enrollment
Primary Investigator:
Reem Sharaiha, MD
Date: December 6, 2018
Pediatric Inflammatory Bowel Disease (IBD) Biobank
Study Status:
Open to Enrollment
Primary Investigator:
Robbyn E. Sockolow, M.D.
Date: January 13, 2017
Research Registry - Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF-PRO)
Study Status:
Open to Enrollment
Primary Investigator:
Robert J. Kaner, M.D.
Date: January 13, 2017
TARGET–NASH: A 5-year Longitudinal Observational Study of Patients with Non-Alcoholic Fatty Liver or Non-Alcoholic Steatohepatitis
Study Status:
Open to Enrollment
Primary Investigator:
Robert S. Brown, MD, MPH
Date: November 9, 2018
IRONMAN: International Registry for Men with Advanced Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Scott Tagawa, MD, MS
Date: September 25, 2018